|
1
|
Shah ASV, Sandoval Y, Noaman A, Sexter A,
Vaswani A, Smith SW, Gibbins M, Griffiths M, Chapman AR, Strachan
FE, et al: Patient selection for high sensitivity cardiac troponin
testing and diagnosis of myocardial infarction: Prospective cohort
study. BMJ. 359(j4788)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bressi E, Mangiacapra F, Ricottini E,
Cavallari I, Colaiori I, Di Gioia G, Creta A, Capuano M, Viscusi MM
and Di Sciascio G: Impact of Neutrophil-to-Lymphocyte ratio and
Platelet-to-lymphocyte ratio on 5-year clinical outcomes of
patients with stable coronary artery disease undergoing elective
percutaneous coronary intervention. J Cardiovasc Transl Res.
11:517–523. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chen X, Shao M, Zhang T, Meng YB, Zhang W,
Huang Z, Xu XG and Li GH: Prognostic value of elevated mean
platelet volume in acute myocardial infarction: A meta-analysis
including 8,945 patients. Int J Clin Exp Med. 12:10151–10163.
2019.
|
|
4
|
Turk J, Fourny M, Yayehd K, Picard N,
Ageron FX, Boussat B, Belle L, Vanzetto G, Puymirat E, Labarère J
and Debaty G: Age-related differences in reperfusion therapy and
outcomes for ST-segment elevation myocardial infarction. J Am
Geriatr Soc. 66:1325–1331. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lin A, Devlin G, Lee M and Kerr AJ:
Performance of the GRACE scores in a New Zealand acute coronary
syndrome cohort. Heart. 100:1960–1966. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shuvy M, Beeri G, Klein E, Cohen T, Shlomo
N, Minha S and Pereg D: Accuracy of the global registry of acute
coronary events (GRACE) risk score in contemporary treatment of
patients with acute coronary syndrome. Can J Cardiol. 34:1613–1617.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gray HH and Henderson RA: The GRACE
score's performance in predicting in-hospital and 1-year outcome.
Heart. 97:1461–1462. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chen YH, Huang SS and Lin SJ: TIMI and
GRACE risk scores predict both short-term and long-term outcomes in
Chinese patients with acute myocardial infarction. Acta Cardiol
Sin. 34:4–12. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Jakimov T, Mrdović I and Filipović B,
Zdravković M, Djoković A, Hinić S, Milić N and Filipović B:
Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of
major adverse cardiac events in patients with acute coronary
syndrome. Croat Med J. 58:406–415. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xiang L, Wang M, You T, Jiao Y, Chen J and
Xu W: Prognostic value of ventricular wall motion score and global
registry of acute coronary events score in patients with acute
myocardial infarction. Am J Med Sci. 354:27–32. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
González-Pacheco H, Bojalil R,
Amezcua-Guerra LM, Sandoval J, Eid-Lidt G, Arias-Mendoza A,
Azar-Manzur F, Álvarez-Sangabriel A, Altamirano-Castillo A,
Briseño-Cruz JL, et al: Derivation and validation of a simple
inflammation-based risk score system for predicting in-hospital
mortality in acute coronary syndrome patients. J Cardiol.
73:416–424. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang JJ, Fan Y, Zhu Y, Zhang JD, Zhang SM,
Wan ZF, Su HL and Jiang N: Biomarkers enhance the long-term
predictive ability of the KAMIR risk score in Chinese patients with
ST-elevation myocardial infarction. Chin Med J (Engl). 132:30–41.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ridker PM, Everett BM, Thuren T, MacFadyen
JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker
SD, et al: Antiinflammatory therapy with canakinumab for
atherosclerotic disease. N Engl J Med. 377:1119–1131.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fuentes QE, Fuentes QF, Andrés V, Pello
OM, Font de Mora J and Palomo GI: Role of platelets as mediators
that link inflammation and thrombosis in atherosclerosis.
Platelets. 24:255–262. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Linden MD and Jackson DE: Platelets:
Pleiotropic roles in atherogenesis and atherothrombosis. Int J
Biochem Cell Biol. 42:1762–1766. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Avci E, Kiris T, Çelik A, Variş E, Esin
FK, Köprülü D and Kadi H: Prognostic value of rising mean platelet
volume during hospitalization in patients with ST-segment elevation
myocardial infarction treated with primary percutaneous coronary
intervention. BMC Cardiovasc Disord. 18(226)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sage AP and Mallat Z: Multiple potential
roles for B cells in atherosclerosis. Ann Med. 46:297–303.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Moriya J: Critical roles of inflammation
in atherosclerosis. J Cardiol. 73:22–27. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hudzik B, Szkodziński J, Lekston A,
Gierlotka M, Poloński L and Gąsior M: Mean platelet
volume-to-lymphocyte ratio: A novel marker of poor short- and
long-term prognosis in patients with diabetes mellitus and acute
myocardial infarction. J Diabetes Complications. 30:1097–1102.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kurtul A and Acikgoz SK: Usefulness of
mean platelet Volume-to-Lymphocyte ratio for predicting
angiographic No-Reflow and Short-Term prognosis after primary
percutaneous coronary intervention in patients with ST-Segment
elevation myocardial infarction. Am J Cardiol. 120:534–541.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
O'Gara PT, Kushner FG, Ascheim DD, Casey
DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM,
Franklin BA, et al: 2013 ACCF/AHA guideline for the management of
ST-elevation myocardial infarction: A report of the American
College of Cardiology Foundation/American Heart Association task
force on practice guidelines. Circulation. 127:e362–e425.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Maruhashi T, Ishihara M, Inoue I, Kawagoe
T, Shimatani Y, Kurisu S, Nakama Y, Kagawa E, Dai K, Matsushita J
and Ikenaga H: Effect of prodromal angina pectoris on the infarct
progression in patients with first ST-elevation acute myocardial
infarction. Circ J. 74:1651–1657. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bayramoğlu A, Taşolar H, Kaya A, Tanboğa
İH, Yaman M, Bektaş O, Günaydın ZY and Oduncu V: Prediction of
no-reflow and major adverse cardiovascular events with a new
scoring system in STEMI patients. J Interv Cardiol. 31:144–149.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fan Z, Li Y, Ji H and Jian X: Prognostic
utility of the combination of monocyte-to-lymphocyte ratio and
neutrophil-to-lymphocyte ratio in patients with NSTEMI after
primary percutaneous coronary intervention: A retrospective cohort
study. BMJ Open. 8(e023459)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shin HC, Jang JS, Jin HY, Seo JS, Yang TH,
Kim DK and Kim DS: Combined use of neutrophil to lymphocyte ratio
and C-reactive protein level to predict clinical outcomes in acute
myocardial infarction patients undergoing percutaneous coronary
intervention. Korean Circ J. 47:383–391. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Celik T, Kaya MG, Akpek M, Gunebakmaz O,
Balta S, Sarli B, Duran M, Demirkol S, Uysal OK, Oguzhan A and
Gibson CM: Predictive value of admission platelet volume indices
for In-hospital major adverse cardiovascular events in acute
ST-segment elevation myocardial infarction. Angiology. 66:155–162.
2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kırış T, Yazici S, Günaydin ZY, Akyüz Ş,
Güzelburç Ö, Atmaca H, Ertürk M, Nazli C and Dogan A: The
prognostic impact of In-hospital change in mean platelet volume in
patients with Non-ST-Segment elevation myocardial infarction.
Angiology. 67:690–696. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Machado GP, Araujo GN, Carpes CK, Lech M,
Mariani S, Valle FH, Bergoli LCC, Gonçalves SC, Wainstein RV and
Wainstein MV: Comparison of Neutrophil-to-Lymphocyte ratio and mean
platelet volume in the prediction of adverse events after primary
percutaneous coronary intervention in patients with ST-elevation
myocardial infarction. Atherosclerosis. 274:212–217.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Monteiro Júnior JGM, Torres DOC, da Silva
MCFC, Martins CMH, da Silva IK, do Nascimento MEM, Dos Santos ACO,
Montarroyos UR and Filho DCS: Prognostic value of hematological
parameters in patients with acute myocardial infarction:
Intrahospital outcomes. PLoS One. 13(e0194897)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ranjith MP, DivyaRaj R, Mathew D, George B
and Krishnan MN: Mean platelet volume and cardiovascular outcomes
in acute myocardial infarction. Heart Asia. 8:16–20.
2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wasilewski J, Desperak P, Hawranek M,
Ciślak A, Osadnik T, Pyka Ł, Gawlita M, Bujak K, Niedziela J,
Krawczyk M and Gąsior M: Prognostic implications of mean platelet
volume on short- and long-term outcomes among patients with
non-ST-segment elevation myocardial infarction treated with
percutaneous coronary intervention: A single-center large
observational study. Platelets. 27:452–458. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Goncalves SC, Labinaz M, Le May M, Glover
C, Froeschl M, Marquis JF, O'Brien E, Shukla D, Ruchin P, Sookur D,
et al: Usefulness of mean platelet volume as a biomarker for
long-term outcomes after percutaneous coronary intervention. Am J
Cardiol. 107:204–209. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Núñez J, Miñana G, Bodí V, Núñez E,
Sanchis J, Husser O and Llàcer A: Low lymphocyte count and
cardiovascular diseases. Curr Med Chem. 18:3226–3233.
2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wagdy S, Sobhy M and Loutfi M:
Neutrophil/lymphocyte ratio as a predictor of In-hospital major
adverse cardiac events, New-onset atrial fibrillation, and
no-reflow phenomenon in patients with ST elevation myocardial
infarction. Clin Med Insights Cardiol. 10:19–22. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gok M, Kundi H, Kiziltunc E, Evlice M,
Cetin M, Suleymanoglu M, Kurtul A and Ornek E: Relationship between
prodromal angina pectoris and Neutrophil-to lymphocyte ratio in
patients with ST elevation myocardial infarction. Heart Lung Circ.
28:901–907. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Heusch G and Gersh BJ: The pathophysiology
of acute myocardial infarction and strategies of protection beyond
reperfusion: A continual challenge. Eur Heart J. 38:774–784.
2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Orbegozo Cortés D, Su F, Santacruz C,
Hosokawa K, Donadello K, Creteur J, De Backer D and Vincent JL:
Ischemic conditioning protects the microcirculation, preserves
organ function, and prolongs survival in sepsis. Shock. 45:419–427.
2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhang H, Qiu B, Zhang Y, Cao Y, Zhang X,
Wu Z, Wang S and Mei L: The value of Pre-infarction angina and
plasma D-Dimer in predicting No-reflow after primary percutaneous
coronary intervention in ST-Segment elevation acute myocardial
infarction patients. Med Sci Monit. 24:4528–4535. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kharbanda RK, Peters M, Walton B,
Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J and
MacAllister R: Ischemic preconditioning prevents endothelial injury
and systemic neutrophil activation during ischemia-reperfusion in
humans in vivo. Circulation. 103:1624–1630. 2001.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ornek E and Kurtul A: Relationship of mean
platelet volume to lymphocyte ratio and coronary collateral
circulation in patients with stable angina pectoris. Coron Artery
Dis. 28:492–497. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kilic A and Kurtul A: RETRACTED: Mean
platelet Volume-to-Lymphocyte ratio as a novel marker for severity
and complexity of coronary atherosclerosis in patients with acute
coronary syndrome. Angiology: Jan 1, 2017 doi:
10.1177/0003319717724274 (Epub ahead of print).
|
|
42
|
Tang EW, Wong CK and Herbison P: Global
registry of acute coronary events (GRACE) hospital discharge risk
score accurately predicts long-term mortality post acute coronary
syndrome. Am Heart J. 153:29–35. 2007.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Moady G, Iakobishvili Z, Beigel R, Shlomo
N, Matetzky S, Zahger D and Atar S: The predictive value of low
admission hemoglobin over the GRACE score in patients with acute
coronary syndrome. J Cardiol. 73:271–275. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhang S, Wan Z, Zhang Y, Fan Y, Gu W, Li
F, Meng L, Zeng X, Han D and Li X: Neutrophil count improves the
GRACE risk score prediction of clinical outcomes in patients with
ST-elevation myocardial infarction. Atherosclerosis. 241:723–728.
2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Klingenberg R, Aghlmandi S, Räber L,
Gencer B, Nanchen D, Heg D, Carballo S, Rodondi N, Mach F,
Windecker S, et al: Improved risk stratification of patients with
acute coronary syndromes using a combination of hsTnT, NT-proBNP
and hsCRP with the GRACE score. Eur Heart J Acute Cardiovasc Care.
7:129–138. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Shahzad S, Mateen S, Hasan A and Moin S:
GRACE score of myocardial infarction patients correlates with
oxidative stress index, hsCRP and inflammation. Immunobiology.
224:433–439. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Fan Y, Wang J, Zhang S, Wan Z, Zhou D,
Ding Y, He Q and Xie P: Homocysteine enhances the predictive value
of the GRACE risk score in patients with ST-elevation myocardial
infarction. Anatol J Cardiol. 18:182–193. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Xiao L, Jia Y, Wang X and Huang H: The
impact of preoperative fibrinogen-albumin ratio on mortality in
patients with acute ST-segment elevation myocardial infarction
undergoing primary percutaneous coronary intervention. Clin Chim
Acta. 493:8–13. 2019.PubMed/NCBI View Article : Google Scholar
|
